Literature DB >> 3756908

Fluorescence anisotropy of cell membranes of doxorubicin-sensitive and -resistant rodent tumoral cells.

D Montaudon, P Vrignaud, D Londos-Gagliardi, J Robert.   

Abstract

We have studied the plasma membrane fluidity of rat C6 glioblastoma cells and simian virus 40-transformed mouse liver cells in culture that had been rendered resistant to doxorubicin. This was done by the evaluation of fluorescence anisotropy of two probes; diphenylhexatriene was used on membrane microsomal fractions, and trimethylammonium-diphenylhexatriene was used on whole cell suspensions as a plasma membrane-specific probe since it does not enter the cells. A higher degree of membrane fluidity was exhibited with both techniques by doxorubicin-resistant glioblastoma cells as compared to the doxorubicin-sensitive strain, but in the transformed liver cells no such alteration was seen in the physical properties of their plasma membranes. A higher degree of acyl group unsaturation was noticed in the glioblastoma cells but not in the transformed liver cells upon acquisition of doxorubicin resistance. A similar simultaneous increase in acyl group unsaturation and membrane fluidity can be obtained easily by growing the sensitive cells with a medium supplemented with exogenous polyunsaturated fatty acids. This alteration does not modify the sensitivity of the cells to doxorubicin. We conclude from our work that the increase in membrane fluidity, which is frequently associated with drug resistance, is neither necessary nor sufficient for the expression of the resistance. The reason for a link between cell resistance to doxorubicin and plasma membrane fluidity remains to be found.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756908

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.

Authors:  Y Lavie; M Liscovitch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 2.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

3.  Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells.

Authors:  Z Kiss; M Tomono; W B Anderson
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

Review 4.  Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells.

Authors:  Y Lavie; G Fiucci; M Czarny; M Liscovitch
Journal:  Lipids       Date:  1999       Impact factor: 1.646

5.  Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma.

Authors:  Burhan Savas; Pauline E Kerr; Hugh F Pross
Journal:  Cancer Cell Int       Date:  2006-11-03       Impact factor: 5.722

Review 6.  Preclinical profile of cabazitaxel.

Authors:  Patricia Vrignaud; Dorothée Semiond; Veronique Benning; Eric Beys; Hervé Bouchard; Sunil Gupta
Journal:  Drug Des Devel Ther       Date:  2014-10-13       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.